Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
Open Access
- 5 January 2012
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 39 (2), 209-219
- https://doi.org/10.1007/s00259-011-2045-0
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older AdultsArchives of Neurology, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Amyloid‐β associated cortical thinning in clinically normal elderlyAnnals of Neurology, 2010
- Spatial relation between microbleeds and amyloid deposits in amyloid angiopathyAnnals of Neurology, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer DiseaseArchives of Neurology, 2009
- Amyloid imaging in mild cognitive impairment subtypesAnnals of Neurology, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Alzheimer Disease and Cognitive ReserveArchives of Neurology, 2008
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004